Q5XCL7 AF NFT | MOLNFT bioinformatics, blockchain

Probable ATP-dependent Clp protease ATP-binding subunit

MOLNFT AF v1 smart contract in GenesisL1 blockchain:

0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD

IPFS of NFT metadata:

bafybeie4jtlvxola5x4hrv37ej2s26lkiocfanv2qqwscuawf7yu4nlogm/metadata.json

IPFS of structure file:

bafybeief4vcsb3vpxvdmpg6lqwtpblpseoc4p32ip7pbywtsbvajwp73sm/AF-Q5XCL7-F1-model_v2.pdb

First NFT owner address (eip-55):

0x4Ef77Afb5a3D9F41c95Be3227D1CC986CCb61835

First NFT owner address (bech32):

genesis1fmmh47668k05rj2muv3868xfsmxtvxp4uykwq9

Current NFT ID #65411 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
65411
Accession (UniProt):
Q5XCL7
Name::
Probable ATP-dependent Clp protease ATP-binding subunit
Experimental Method:
Predicted structure
Sequence source:
Streptococcus pyogenes serotype M6 (strain ATCC BAA-946 / MGAS10394)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q5XCL7 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q5XCL7|CLPC_STRP6 Probable ATP-dependent Clp protease ATP-binding subunit OS=Streptococcus pyogenes serotype M6 (strain ATCC BAA-946 / MGAS10394) OX=286636 GN=clpC PE=1 SV=1 MTHFSGKDPFVNMDDIFNQLMANMGGYRSENPRYLVNGREITPEEFQHYRQTGQLPVATTKATNSQMLTPKADSVLTQLGTNLTQEARQGHLDPVIGRNKEIQDTAEILARRTKNNPVLVGDAGVGKTAVIEGLAQAIVNGDVPAAIKNKEIVSIDISSLEAGTQYRGSFEETIQNLIQEVKEAGNIILFFDEIHQIVGAGATSSDSGSKGLADILKPALSRGELTLIGATTQDEYRNTILKNAALARRFNEVKVNAPSAEDTFHILMGIRNLYEQHHHITLPDNVLKAAVDYSIQYIPQRSLPDKAIDLLDMTAAHLAAQHPVTDLKTLETEIAKQKESQEKAVAKEDFEKALAAKTRIETLQKQIEQHNQSQNVTATVNDIAESVERLTGIPVSNMRTNDLERLKGISSRLKSHVIGQDEAVAAVARAIRRNRAGFDDGNRPIGSFLFVGPTGVGKTELAKQLALDLFGSKDAIIRLDMSEYNDRTAVSKLIGTTAGYVGYDDNNNTLTERVRRNPYAIVLLDEIEKADPQIITLLLQVLDDGRLTDGQGNTINFKNTVIIATSNAGFGQQDTETSESNIMDRIAPYFRPEFLNRFNSIIKFNHLQKENLEEIVDLMLAEVNQTTAKKGISLTIADDAKAHLIDLGYNHAMGARPLRRIIEQEIRDRITDYYLDHPEVKKLQAILKEGQLVIRQNDQ